178 related articles for article (PubMed ID: 10447832)
21. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration.
McKellar Q; Gibson I; Monteiro A; Bregante M
Antimicrob Agents Chemother; 1999 Aug; 43(8):1988-92. PubMed ID: 10428924
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study.
de Lucas JJ; Rodríguez C; Martella MB; Lábaque MC; Navarro JL; San Andrés MI
Res Vet Sci; 2005 Jun; 78(3):265-7. PubMed ID: 15766947
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of enrofloxacin after single-dose oral and intravenous administration in the American alligator (Alligator mississippiensis).
Helmick KE; Papich MG; Vliet KA; Bennett RA; Jacobson ER
J Zoo Wildl Med; 2004 Sep; 35(3):333-40. PubMed ID: 15526888
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetics of baytril (enrofloxacin) in dogs].
Küng K; Wanner M
Schweiz Arch Tierheilkd; 1994; 136(10):329-34. PubMed ID: 7801085
[TBL] [Abstract][Full Text] [Related]
25. Concentration of enrofloxacin and its metabolite ciprofloxacin in canine matrices of the locomotor system.
Ehinger AM; Meyer-Lindenberg A; Vick M; Nolte I; Kietzmann M
J Vet Med A Physiol Pathol Clin Med; 2002 Mar; 49(2):99-104. PubMed ID: 11958474
[TBL] [Abstract][Full Text] [Related]
26. The disposition of five therapeutically important antimicrobial agents in llamas.
Christensen JM; Smith BB; Murdane SB; Hollingshead N
J Vet Pharmacol Ther; 1996 Dec; 19(6):431-8. PubMed ID: 8971671
[TBL] [Abstract][Full Text] [Related]
27. Limited capacity of neonatal rabbits to eliminate enrofloxacin and ciprofloxacin.
Fraile LJ; Martinez C; Aramayona JJ; Abadía AR; Bregante MA; García MA
Vet Q; 1997 Nov; 19(4):162-7. PubMed ID: 9413113
[TBL] [Abstract][Full Text] [Related]
28. Endometrial tissue concentrations of enrofloxacin after intrauterine administration to mares.
Fumuso E; Checura C; Losinno L; Soto P; Sánchez S
Vet Res Commun; 2002 Jul; 26(5):371-80. PubMed ID: 12212727
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration.
Kaartinen L; Panu S; Pyörälä S
Equine Vet J; 1997 Sep; 29(5):378-81. PubMed ID: 9306065
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and residues of enrofloxacin in chickens.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Bringas P; Martínez MA; Fernàndez-Cruz ML; Fernández MC; Fernández R
Am J Vet Res; 1995 Apr; 56(4):501-6. PubMed ID: 7785830
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats.
Elmas M; Tras B; Kaya S; Bas AL; Yazar E; Yarsan E
Can J Vet Res; 2001 Jan; 65(1):64-7. PubMed ID: 11227198
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in cows following single dose intravenous administration.
Varma R; Ahmad AH; Sharma LD; Aggarwal P; Ahuja V
J Vet Pharmacol Ther; 2003 Aug; 26(4):303-5. PubMed ID: 12887614
[No Abstract] [Full Text] [Related]
33. Pharmacokinetics of enrofloxacin in newborn and one-week-old calves.
Kaartinen L; Pyörälä S; Moilanen M; Räisänen S
J Vet Pharmacol Ther; 1997 Dec; 20(6):479-82. PubMed ID: 9430772
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog.
Cester CC; Toutain PL
J Pharm Sci; 1997 Oct; 86(10):1148-55. PubMed ID: 9344173
[TBL] [Abstract][Full Text] [Related]
35. Intravenous pharmacokinetics of ciprofloxacin in goats.
García Ovando H; Gorla N; Poloni G; Trotti N; Prieto G; Errecalde C
Int J Antimicrob Agents; 2000 Jun; 15(1):77-9. PubMed ID: 10856681
[TBL] [Abstract][Full Text] [Related]
36. Enrofloxacin-based therapeutic strategy for the prevention of endometritis in susceptible mares.
González C; Moreno L; Fumuso E; García J; Rivulgo M; Confalonieri A; Sparo M; Sánchez Bruni S
J Vet Pharmacol Ther; 2010 Jun; 33(3):287-94. PubMed ID: 20557446
[TBL] [Abstract][Full Text] [Related]
37. Disposition kinetics of danofloxacin and ciprofloxacin in broiler chickens.
el-Gendi AY; el-Banna HA; Abo Norag M; Gaber M
Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):429-34. PubMed ID: 11721591
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic disposition of subcutaneously administered enrofloxacin in goats.
Ramesh S; Rao GS; Malik JK
Vet Res Commun; 2002 Oct; 26(7):563-9. PubMed ID: 12416871
[TBL] [Abstract][Full Text] [Related]
39. Comparison of an HPLC and bioassay method to determine antimicrobial concentrations after intravenous and oral administration of enrofloxacin in four dogs.
Küng K; Riond JL; Wolffram S; Wanner M
Res Vet Sci; 1993 Mar; 54(2):247-8. PubMed ID: 8384728
[TBL] [Abstract][Full Text] [Related]
40. Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration.
Heinen E
J Vet Pharmacol Ther; 2002 Feb; 25(1):1-5. PubMed ID: 11874520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
